Clexane Forte is a medicine containing the active ingredient(s) enoxaparin sodium. On this page you will find out more about Clexane Forte, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: enoxaparin sodium
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Clexane Forte 150 mg/mL injection solution, 15 x 1 mL syringes
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. Prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. Prevention of thrombosis in extra-corporeal circulation during haemodialysis. Treatment of established deep vein thrombosis. Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin. Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).
Table of characteristics
|Visual appearance||Clear, colourless to pale yellow solution dispensed in double graduated (mL/mg) syringes closed with a grey synthetic rubber shield and fitted with a black synthetic rubber piston.|
|Dosage Form||Injection, solution|
|Route of administration||Subcutaneous|
10 x 1mL prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy
15 x 1mL prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy
8 x 1mL prefilled syringes: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Do not Freeze|
|Life time||24 Months|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.